Eris Lifesciences Executive and Leadership Team

V. Krishnakumar, the Executive Director & Chief Operating Officer at Eris Lifesciences, directs the internal operational framework to ensure seamless production of branded formulations. Overseeing the cardio-metabolic manufacturing divisions, the Executive Director & Chief Operating Officer optimizes resource allocation to maintain high standards in pharmaceutical quality. This leadership role involves coordinating with cross-functional teams to streamline the supply chain across the Indian market. By implementing rigorous efficiency protocols, V. Krishnakumar drives the company toward sustainable growth in the competitive pharmaceutical sector. The Executive Director & Chief Operating Officer monitors performance metrics to align daily activities with long-term corporate objectives. Through constant evaluation of manufacturing processes, the Executive Director & Chief Operating Officer secures the operational integrity required to support the diverse therapeutic portfolio, including anti-diabetes and cardiovascular health products, while maintaining strict adherence to regulatory compliance standards across all regional facilities.

Gagan Atreja, the President, Operations at Eris Lifesciences, manages the logistical infrastructure and distribution networks necessary for delivering pharmaceutical products to healthcare professionals. Overseeing the national supply chain, the President, Operations ensures that dermatology and gynecology formulations reach target markets with maximum efficiency. This leadership role requires constant collaboration with procurement teams to stabilize inventory levels for chronic lifestyle-related disease treatments. By refining distribution channels, Gagan Atreja enhances the availability of essential medications throughout India. The President, Operations evaluates logistical performance to identify opportunities for cost reduction and service improvement. Through strategic oversight of regional warehousing and transport, the President, Operations maintains the reliability of the product delivery system. This focus on operational excellence supports the broader mission of improving patient care by ensuring that critical health solutions remain accessible to patients and providers in every corner of the domestic market.

R. Murari, the President at Eris Lifesciences, architects the overarching corporate strategy to strengthen the market position within the Indian pharmaceutical landscape. Overseeing high-level business development, the President aligns the company portfolio with emerging needs in the cardio-metabolic sector. This leadership role involves engaging with the Board to define long-term growth trajectories and investment priorities. By fostering innovation in chronic disease management, R. Murari drives the organization toward pioneering new therapeutic studies. The President monitors competitive dynamics to adjust strategic initiatives, ensuring the company remains a leader in branded formulations. Through consistent interaction with key stakeholders, the President secures the resources needed for expanding the reach of anti-diabetes and cardiovascular health products. This executive focus on strategic vision ensures that the company maintains a robust presence, consistently delivering value to healthcare professionals and patients while navigating the complexities of the evolving pharmaceutical industry.

Manoj Mallick, the Markrting at Eris Lifesciences, designs comprehensive promotional strategies to increase awareness of branded formulations among healthcare professionals. Overseeing the brand management teams, the Markrting executes campaigns that highlight the efficacy of treatments for anti-diabetes and cardiovascular health. This leadership role involves analyzing market data to tailor messaging for specific therapeutic areas like dermatology and gynecology. By optimizing the engagement funnel, Manoj Mallick drives demand for the company's diverse product range across India. The Markrting collaborates with sales leadership to ensure that promotional activities translate into improved patient care outcomes. Through the development of educational initiatives, the Markrting positions the company as a trusted partner for medical practitioners. This focus on market penetration and brand equity supports the company's goal of addressing chronic lifestyle-related diseases, ensuring that the value proposition of every formulation reaches the intended clinical audience effectively.